Nymox Pharmaceutical (NYMXF) Liabilities and Shareholders Equity (2015 - 2025)
Nymox Pharmaceutical's Liabilities and Shareholders Equity came in at $576,000 for Q4 2025, down 11.9% from $654,000 a year earlier.
Powered by 
Analysis
Nymox Pharmaceutical (NYMXF) Liabilities and Shareholders Equity (2015 - 2025) Analysis & Trends
Going back to Q4 2015, Nymox Pharmaceutical's Liabilities and Shareholders Equity data covers 30 quarters.
- Liabilities and Shareholders Equity carries a five-year compound annual growth rate of -33.2% (FY2020 to FY2025).
- Going back by year, Liabilities and Shareholders Equity was $654,000 in FY2024 (+4.3%), $627,000 in FY2023 (-61.4%), $1.63 million in FY2022 (+12.6%) and $1.44 million in FY2021 (-66.8%).
- The Q4 2025 figure represents the lowest quarterly Liabilities and Shareholders Equity since Q2 2023.
- The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q2 2021 (growth of 532.2%), and the weakest in Q2 2023 (a decline of 93.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Nymox Pharmaceutical | 6.12 Mn | 5.93 Mn | - | 576,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 576,000.00 |
| Dec 31, 2024 | 654,000.00 |
| Sep 30, 2024 | 624,000.00 |
| Dec 31, 2023 | 627,000.00 |
| Sep 30, 2023 | 669,000.00 |
| Jun 30, 2023 | 271,000.00 |
| Mar 31, 2023 | 575,000.00 |
| Dec 31, 2022 | 1.63 Mn |
| Sep 30, 2022 | 3.14 Mn |
| Jun 30, 2022 | 4.47 Mn |
| Mar 31, 2022 | 1.24 Mn |
| Dec 31, 2021 | 1.44 Mn |
| Sep 30, 2021 | 3.85 Mn |
| Jun 30, 2021 | 6.67 Mn |
| Mar 31, 2021 | 1.46 Mn |
| Dec 31, 2020 | 4.34 Mn |
| Sep 30, 2020 | 5.74 Mn |
| Jun 30, 2020 | 1.06 Mn |
| Mar 31, 2020 | 3.37 Mn |
| Dec 31, 2019 | 5.49 Mn |
API Access
Nymox Pharmaceutical Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NYMXF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "NYMXF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=NYMXF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();